IL18 and atherosclerosis: It is difficult to ascertain if IL-18 is a good indicator of severity of atherosclerosis, but it seems to be a good indicator of its clinical complications among patient suffering from CKD, without diabetes mellitus, and with AMI in the year prior to the enrolment.